REFERENCES
1. Emmerich SD, Fryar CD, Stierman B, Ogden CL. Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023. NCHS Data Brief. 2024.
2. WHO. Obesity and Overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. [Last accessed on 27 Feb 2026].
3. Solis-Herrera C, Triplitt C, Cersosimo E, DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. South Dartmouth (MA): MDText.com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279115/. [Last accessed on 27 Feb 2026].
5. Jastreboff AM, Aronne LJ, Ahmad NN, et al; SURMOUNT-1 Investigators. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205-16.
6. Rader B, Hazan R, Brownstein JS. Changes in adult obesity trends in the US. JAMA Health Forum. 2024;5:e243685.
7. Jensen SBK, Sørensen V, Sandsdal RM, et al. Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2024;7:e2416775.
8. Wilding JPH, Batterham RL, Calanna S, et al; STEP 1 Study Group. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989-1002.
9. Cooke NE. Rat vitamin D binding protein. Determination of the full-length primary structure from cloned cDNA. J Biol Chem. ;261:3441-50.
10. Haddad JG Jr., Walgate J. 25-Hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifidiol-binding protein. J Biol Chem. 1976;251:4803-9.
11. Hirschfeld J. Immune-electrophoretic demonstration of qualitative differences in human sera and their relation to the haptoglobins. Acta Pathol Microbiol Scand. 1959;47:160-8.
12. Hirschfeld J, Jonsson B, Rasmuson M. Inheritance of a new group-specific system demonstrated in normal human sera by means of an immuno-electrophoretic technique. Nature. 1960;185:931-2.
13. Hirschfeld J, Soderberg U. Immuno-electrophoretic demonstration of precipitating components in sera from pregnant women. Nature. 1960;187:332-3.
14. Malik S, Fu L, Juras DJ, et al. Common variants of the vitamin D binding protein gene and adverse health outcomes. Crit Rev Clin Lab Sci. 2013;50:1-22.
15. Roger B, Rene FC, Frans S. Chapter 7 - vitamin D-binding protein. In: Hewison M, Bouillon R, Giovannucci E, Goltzman D, Meyer M, Welsh JE, Editors. Feldman and Pike’s Vitamin D. New York: Elsevier; 2024. pp. 111-138.
16. Head JF, Swamy N, Ray R. Crystal structure of the complex between actin and human vitamin D-binding protein at 2.5 A resolution. Biochemistry. 2002;41:9015-20.
17. Otterbein LR, Cosio C, Graceffa P, Dominguez R. Crystal structures of the vitamin D-binding protein and its complex with actin: structural basis of the actin-scavenger system. Proc Natl Acad Sci U S A. 2002;99:8003-8.
18. Verboven C, Bogaerts I, Waelkens E, et al. Actin-DBP: the perfect structural fit? Acta Crystallogr D Biol Crystallogr. 2003;59:263-73.
19. Verboven C, Rabijns A, De Maeyer M, Van Baelen H, Bouillon R, De Ranter C. A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Biol. 2002;9:131-6.
20. Daiger SP, Schanfield MS, Cavalli-Sforza LL. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci U S A. 1975;72:2076-80.
21. Zhang J, Kew RR. Identification of a region in the vitamin D-binding protein that mediates its C5a chemotactic cofactor function. J Biol Chem. 2004;279:53282-7.
22. Kew RR, Mollison KW, Webster RO. Binding of Gc globulin (vitamin D binding protein) to C5a or C5a des Arg is not necessary for co-chemotactic activity. J Leukoc Biol. 1995;58:55-8.
23. Zhang J, Habiel DM, Ramadass M, Kew RR. Identification of two distinct cell binding sequences in the vitamin D binding protein. Biochim Biophys Acta. 2010;1803:623-9.
24. Bouillon R, Xiang DZ, Convents R, Van Baelen H. Polyunsaturated fatty acids decrease the apparent affinity of vitamin D metabolites for human vitamin D-binding protein. J Steroid Biochem Mol Biol. 1992;42:855-61.
25. Van Baelen H, Bouillon R, De Moor P. Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem. 1980;255:2270-2.
26. Buch S, Gremm D, Wegner A, Mannherz HG. Binding of a C-terminal fragment (residues 369 to 435) of vitamin D-binding protein to actin. Biol Chem. 2002;383:1621-31.
27. Swamy N, Head JF, Weitz D, Ray R. Biochemical and preliminary crystallographic characterization of the vitamin D sterol- and actin-binding by human vitamin D-binding protein. Arch Biochem Biophys. 2002;402:14-23.
28. Haddad JG, Hu YZ, Kowalski MA, et al. Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (Gc-globulin). Biochemistry. 1992;31:7174-81.
29. Mc Leod JF, Kowalski MA, Haddad JG Jr. Interactions among serum vitamin D binding protein, monomeric actin, profilin, and profilactin. J Biol Chem. 1989;264:1260-7.
30. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986;63:954-9.
31. Bikle DD, Siiteri PK, Ryzen E, Haddad JG. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab. 1985;61:969-75.
32. Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev. 1989;10:232-74.
33. Nykjaer A, Dragun D, Walther D, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999;96:507-15.
34. Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol. 2002;3:256-66.
35. Ray R. Molecular recognition in vitamin D-binding protein. Proc Soc Exp Biol Med. 1996;212:305-12.
36. Swamy N, Dutta A, Ray R. Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein. Biochemistry. 1997;36:7432-6.
37. Safadi FF, Thornton P, Magiera H, et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999;103:239-51.
38. Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr Rev. 1990;11:80-91.
39. Binder R, Kress A, Kan G, Herrmann K, Kirschfink M. Neutrophil priming by cytokines and vitamin D binding protein (Gc-globulin): impact on C5a-mediated chemotaxis, degranulation and respiratory burst. Mol Immunol. 1999;36:885-92.
40. Kew RR, Webster RO. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. J Clin Invest. 1988;82:364-9.
41. Piquette CA, Robinson-Hill R, Webster RO. Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin. J Leukoc Biol. 1994;55:349-54.
42. Senior RM, Griffin GL, Perez HD, Webster RO. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts. J Immunol. 1988;141:3570-4.
43. DiMartino SJ, Shah AB, Trujillo G, Kew RR. Elastase controls the binding of the vitamin D-binding protein (Gc-globulin) to neutrophils: a potential role in the regulation of C5a co-chemotactic activity. J Immunol. 2001;166:2688-94.
44. Kew RR, Fisher JA, Webster RO. Co-chemotactic effect of Gc-globulin (vitamin D binding protein) for C5a. Transient conversion into an active co-chemotaxin by neutrophils. J Immunol. 1995;155:5369-74.
45. Metcalf JP, Thompson AB, Gossman GL, et al. Gcglobulin functions as a cochemotaxin in the lower respiratory tract. A potential mechanism for lung neutrophil recruitment in cigarette smokers. Am Rev Respir Dis. 1991;143:844-9.
46. Yamamoto N, Naraparaju VR. Role of vitamin D3-binding protein in activation of mouse macrophages. J Immunol. 1996;157:1744-9.
47. Mohamad SB, Nagasawa H, Uto Y, Hori H. Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities. Anticancer Res. 2002;22:4297-300.
48. Nagasawa H, Uto Y, Sasaki H, et al. Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. Anticancer Res. 2005;25:3689-95.
49. Debruyne E, Speeckaert M, Weygaerde YV, Delanghe J. Phenotype of Gc-globulin influences the macrophage activating factor (MAF) levels in serum. Clin Chem Lab Med. 2011;49:1855-60.
50. Yamamoto N, Homma S, Millman I. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. J Immunol. 1991;147:273-80.
51. Gumireddy K, Reddy CD, Swamy N. Mitogen-activated protein kinase pathway mediates DBP-maf-induced apoptosis in RAW 264.7 macrophages. J Cell Biochem. 2003;90:87-96.
52. Kisker O, Onizuka S, Becker CM, et al. Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia. 2003;5:32-40.
53. Schneider GB, Benis KA, Flay NW, Ireland RA, Popoff SN. Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone. 1995;16:657-62.
54. Swamy N, Ghosh S, Schneider GB, Ray R. Baculovirus-expressed vitamin D-binding protein-macrophage activating factor (DBP-maf) activates osteoclasts and binding of 25-hydroxyvitamin D(3) does not influence this activity. J Cell Biochem. 2001;81:535-46.
55. Schneider GB, Grecco KJ, Safadi FF, Popoff SN. The anabolic effects of vitamin D-binding protein-macrophage activating factor (DBP-MAF) and a novel small peptide on bone. Crit Rev Eukaryot Gene Expr. 2003;13:277-84.
56. Lee WM, Galbraith RM. The extracellular actin-scavenger system and actin toxicity. N Engl J Med. 1992;326:1335-41.
57. Meier U, Gressner O, Lammert F, Gressner AM. Gc-globulin: roles in response to injury. Clin Chem. 2006;52:1247-53.
58. Ge L, Trujillo G, Miller EJ, Kew RR. Circulating complexes of the vitamin D binding protein with G-actin induce lung inflammation by targeting endothelial cells. Immunobiology. 2014;219:198-207.
59. Minikel EV, Painter JL, Dong CC, Nelson MR. Refining the impact of genetic evidence on clinical success. Nature. 2024;629:624-9.
60. Cleve H, Constans J. The mutants of the vitamin-D-binding protein: more than 120 variants of the GC/DBP system. Vox Sang. 1988;54:215-25.
61. Alathari BE, Sabta AA, Kalpana CA, Vimaleswaran KS. Vitamin D pathway-related gene polymorphisms and their association with metabolic diseases: a literature review. J Diabetes Metab Disord. 2020;19:1701-29.
62. Trefilio LM, Bottino L, de Carvalho Cardoso R, Montes GC, Fontes-Dantas FL. The impact of genetic variants related to vitamin D and autoimmunity: a systematic review. Heliyon. 2024;10:e27700.
63. Rozmus D, Płomiński J, Augustyn K, Cieślińska A. rs7041 and rs4588 polymorphisms in vitamin D binding protein gene (VDBP) and the risk of diseases. Int J Mol Sci. 2022;23:933.
64. Loya H, Kalantzis G, Cooper F, Palamara PF. A scalable variational inference approach for increased mixed-model association power. Nat Genet. 2025;57:461-8.
65. Moy KA, Mondul AM, Zhang H, et al. Genome-wide association study of circulating vitamin D-binding protein. Am J Clin Nutr. 2014;99:1424-31.
66. Palmer ND, Lu L, Register TC, et al. Genome-wide association study of vitamin D concentrations and bone mineral density in the African American-Diabetes Heart Study. PLoS One. 2021;16:e0251423.
67. Caron B, Patin E, Rotival M, et al; Milieu Intérieur Consortium. Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes. Genome Med. 2022;14:28.
68. Albiñana C, Zhu Z, Borbye-Lorenzen N, et al. Genetic correlates of vitamin D-binding protein and 25-hydroxyvitamin D in neonatal dried blood spots. Nat Commun. 2023;14:852.
69. Surapaneni A, Schlosser P, Zhou L, et al. Identification of 969 protein quantitative trait loci in an African American population with kidney disease attributed to hypertension. Kidney Int. 2022;102:1167-77.
70. Parlato LA, Welch R, Ong IM, et al. Genome-wide association study (GWAS) of circulating vitamin D outcomes among individuals of African ancestry. Am J Clin Nutr. 2023;117:308-16.
71. Pietzner M, Wheeler E, Carrasco-Zanini J, et al. Mapping the proteo-genomic convergence of human diseases. Science. 2021;374:eabj1541.
72. Ahn J, Yu K, Stolzenberg-Solomon R, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010;19:2739-45.
73. Choe EK, Shivakumar M, Verma A, et al. Leveraging deep phenotyping from health check-up cohort with 10,000 Korean individuals for phenome-wide association study of 136 traits. Sci Rep. 2022;12:1930.
74. Jacobs BM, Stow D, Hodgson S, et al; Genes & Health Research Team. Genetic architecture of routinely acquired blood tests in a British South Asian cohort. Nat Commun. 2024;15:8929.
75. Jiang X, O’Reilly PF, Aschard H, et al. Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nat Commun. 2018;9:260.
76. Lasky-Su J, Lange N, Brehm JM, et al. Genome-wide association analysis of circulating vitamin D levels in children with asthma. Hum Genet. 2012;131:1495-505.
77. Qiu S, Zheng K, Hu Y, Liu G. Genetic correlation, causal relationship, and shared loci between vitamin D and COVID-19: a genome-wide cross-trait analysis. J Med Virol. 2023;95:e28780.
78. Sinnott-Armstrong N, Tanigawa Y, Amar D, et al; FinnGen. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nat Genet. 2021;53:185-94.
79. Verma A, Huffman JE, Rodriguez A, et al. Diversity and scale: genetic architecture of 2068 traits in the VA million veteran program. Science. 2024;385:eadj1182.
80. Sun W, Kechris K, Jacobson S, et al; SPIROMICS Research Group, COPDGene Investigators. Common genetic polymorphisms influence blood biomarker measurements in COPD. PLoS Genet. 2016;12:e1006011.
81. Amin HA, Drenos F. No evidence that vitamin D is able to prevent or affect the severity of COVID-19 in individuals with European ancestry: a Mendelian randomisation study of open data. BMJ Nutr Prev Health. 2021;4:42-8.
82. Anderson D, Holt BJ, Pennell CE, Holt PG, Hart PH, Blackwell JM. Genome-wide association study of vitamin D levels in children: replication in the Western Australian Pregnancy Cohort (Raine) study. Genes Immun. 2014;15:578-83.
83. Hong J, Hatchell KE, Bradfield JP, et al. Transethnic evaluation identifies low-frequency loci associated with 25-hydroxyvitamin D concentrations. J Clin Endocrinol Metab. 2018;103:1380-92.
84. Kämpe A, Enlund-Cerullo M, Valkama S, et al. Genetic variation in GC and CYP2R1 affects 25-hydroxyvitamin D concentration and skeletal parameters: a genome-wide association study in 24-month-old Finnish children. PLoS Genet. 2019;15:e1008530.
85. Kim YA, Yoon JW, Lee Y, et al. Unveiling genetic variants underlying vitamin D deficiency in multiple korean cohorts by a genome-wide association study. Endocrinol Metab. 2021;36:1189-200.
86. Manousaki D, Dudding T, Haworth S, et al. Low-frequency synonymous coding variation in CYP2R1 has large effects on vitamin D levels and risk of multiple sclerosis. Am J Hum Genet. 2017;101:227-38.
87. Manousaki D, Mitchell R, Dudding T, et al. Genome-wide association study for vitamin D levels reveals 69 independent loci. Am J Hum Genet. 2020;106:327-37.
88. O’Brien KM, Sandler DP, Shi M, Harmon QE, Taylor JA, Weinberg CR. Genome-wide association study of serum 25-hydroxyvitamin D in US women. Front Genet. 2018;9:67.
89. Revez JA, Lin T, Qiao Z, et al. Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration. Nat Commun. 2020;11:1647.
90. Sallinen RJ, Dethlefsen O, Ruotsalainen S, et al. Genetic risk score for serum 25-hydroxyvitamin D concentration helps to guide personalized vitamin D supplementation in healthy finnish adults. J Nutr. 2021;151:281-92.
91. Sampathkumar A, Tan KM, Chen L, et al. Genetic link determining the maternal-fetal circulation of vitamin D. Front Genet. 2021;12:721488.
92. Seo J, Gaddis NC, Patchen BK, et al. Exploiting meta-analysis of genome-wide interaction with serum 25-hydroxyvitamin D to identify novel genetic loci associated with pulmonary function. Am J Clin Nutr. 2024;119:1227-37.
93. Traglia M, Windham GC, Pearl M, et al. Genetic contributions to maternal and neonatal vitamin D levels. Genetics. 2020;214:1091-102.
94. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376:180-8.
95. Wang X, Hivert V, Groot S, et al. Cross-ancestry analyses identify new genetic loci associated with 25-hydroxyvitamin D. PLoS Genet. 2023;19:e1011033.
96. Vuckovic D, Bao EL, Akbari P, et al; VA Million Veteran Program. The polygenic and monogenic basis of blood traits and diseases. Cell. 2020;182:1214-31.e11.
97. Sakaue S, Kanai M, Tanigawa Y, et al; FinnGen. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53:1415-24.
98. Astle WJ, Elding H, Jiang T, et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell. 2016;167:1415-29.e19.
99. Chen MH, Raffield LM, Mousas A, et al; VA Million Veteran Program. Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations. Cell. 2020;182:1198-213.e14.
100. Kachuri L, Jeon S, DeWan AT, et al. Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia. Am J Hum Genet. 2021;108:1823-35.
101. Kichaev G, Bhatia G, Loh PR, et al. Leveraging polygenic functional enrichment to improve GWAS power. Am J Hum Genet. 2019;104:65-75.
102. Ahsan M, Ek WE, Rask-Andersen M, et al. The relative contribution of DNA methylation and genetic variants on protein biomarkers for human diseases. PLoS Genet. 2017;13:e1007005.
103. Konieczny MJ, Omarov M, Zhang L, et al. The genomic architecture of circulating cytokine levels points to drug targets for immune-related diseases. Commun Biol. 2025;8:34.
104. Graham SE, Clarke SL, Wu KH, et al; VA Million Veteran Program, Global Lipids Genetics Consortium*. The power of genetic diversity in genome-wide association studies of lipids. Nature. 2021;600:675-9.
105. Karjalainen MK, Karthikeyan S, Oliver-Williams C, et al; China Kadoorie Biobank Collaborative Group, Estonian Biobank Research Team, FinnGen. Genome-wide characterization of circulating metabolic biomarkers. Nature. 2024;628:130-8.
106. Inouye M, Ripatti S, Kettunen J, et al. Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet. 2012;8:e1002907.
107. Kiiskinen T, Helkkula P, Krebs K, et al; FinnGen. Genetic predictors of lifelong medication-use patterns in cardiometabolic diseases. Nat Med. 2023;29:209-18.
108. Pozarickij A, Gan W, Lin K, et al; China Kadoorie Biobank Collaborative Group. Causal relevance of different blood pressure traits on risk of cardiovascular diseases: GWAS and Mendelian randomisation in 100,000 Chinese adults. Nat Commun. 2024;15:6265.
109. Asiimwe IG, Blockman M, Cohen K, et al. A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients. Front Pharmacol. 2022;13:967082.
110. He D, Liu H, Wei W, et al. A longitudinal genome-wide association study of bone mineral density mean and variability in the UK Biobank. Osteoporos Int. 2023;34:1907-16.
111. Adams LA, White SW, Marsh JA, et al. Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease. Hepatology. 2013;57:590-600.
112. Arpawong TE, Pendleton N, Mekli K, et al. Genetic variants specific to aging-related verbal memory: insights from GWASs in a population-based cohort. PLoS One. 2017;12:e0182448.
113. Foss-Skiftesvik J, Li S, Rosenbaum A, et al. Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus. Neuro Oncol. 2023;25:1709-20.
114. Hall LS, Adams MJ, Arnau-Soler A, et al; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Genome-wide meta-analyses of stratified depression in Generation Scotland and UK Biobank. Transl Psychiatry. 2018;8:9.
115. Fan W, Kan H, Liu HY, et al. Association between human genetic variants and the vaginal bacteriome of pregnant women. mSystems. 2021;6:e0015821.
116. Hysi PG, Choquet H, Khawaja AP, et al; Consortium for Refractive Error and Myopia, UK Eye and Vision Consortium, 23andMe Inc. Meta-analysis of 542,934 subjects of European ancestry identifies new genes and mechanisms predisposing to refractive error and myopia. Nat Genet. 2020;52:401-7.
117. Liu J, Zhou Y, Liu S, et al; DISCO (Deciphering disorders Involving Scoliosis and COmorbidities) Study. The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease. Hum Genet. 2018;137:553-67.
118. Pasanen A, Karjalainen MK, Zhang G, et al; FinnGen. Meta-analysis of genome-wide association studies of gestational duration and spontaneous preterm birth identifies new maternal risk loci. PLoS Genet. 2023;19:e1010982.
119. Tian C, Hromatka BS, Kiefer AK, et al. Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections. Nat Commun. 2017;8:599.
120. Yengo L, Vedantam S, Marouli E, et al; 23andMe Research Team, VA Million Veteran Program, DiscovEHR (DiscovEHR and MyCode Community Health Initiative), eMERGE (Electronic Medical Records and Genomics Network), Lifelines Cohort Study, PRACTICAL Consortium, Understanding Society Scientific Group. A saturated map of common genetic variants associated with human height. Nature. 2022;610:704-12.
121. Gallois A, Mefford J, Ko A, et al. A comprehensive study of metabolite genetics reveals strong pleiotropy and heterogeneity across time and context. Nat Commun. 2019;10:4788.
122. Gudjonsson A, Gudmundsdottir V, Axelsson GT, et al. A genome-wide association study of serum proteins reveals shared loci with common diseases. Nat Commun. 2022;13:480.
123. He B, Shi J, Wang X, Jiang H, Zhu HJ. Genome-wide pQTL analysis of protein expression regulatory networks in the human liver. BMC Biol. 2020;18:97.
124. Sun BB, Maranville JC, Peters JE, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558:73-9.
125. Tabassum R, Ruotsalainen S, Ottensmann L, et al. Lipidome- and genome-wide study to understand sex differences in circulatory lipids. J Am Heart Assoc. 2022;11:e027103.
126. Kurki MI, Karjalainen J, Palta P, et al; FinnGen. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508-18.
127. Wang Q, Dhindsa RS, Carss K, et al; AstraZeneca Genomics Initiative. Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature. 2021;597:527-32.
128. Banerjee RR, Spence T, Frank SJ, et al. Very low vitamin D in a patient with a novel pathogenic variant in the GC gene that encodes vitamin D-binding protein. J Endocr Soc. 2021;5:bvab104.
129. Henderson CM, Fink SL, Bassyouni H, et al. Vitamin D-binding protein deficiency and homozygous deletion of the GC gene. N Engl J Med. 2019;380:1150-7.
130. Kuo T, Damle M, González BJ, Egli D, Lazar MA, Accili D. Induction of α cell-restricted Gc in dedifferentiating β cells contributes to stress-induced β-cell dysfunction. JCI Insight. 2019;5:e128351.
131. de Souza GO, Wasinski F, Donato J Jr. Characterization of the metabolic differences between male and female C57BL/6 mice. Life Sci. 2022;301:120636.
132. Pettersson US, Waldén TB, Carlsson PO, Jansson L, Phillipson M. Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS One. 2012;7:e46057.
133. Stapleton S, Welch G, DiBerardo L, Freeman LR. Sex differences in a mouse model of diet-induced obesity: the role of the gut microbiome. Biol Sex Differ. 2024;15:5.
134. Gill R, Kuo T. Gc inhibition preserves insulin sensitivity and reduces body weight without loss of muscle mass. JCI Insight. 2025;10:e195341.
135. Ikeda K, Yamada T. UCP1 dependent and independent thermogenesis in brown and beige adipocytes. Front Endocrinol. 2020;11:498.
136. Dong W, Li Q, Lu X, et al. Ceramide kinase-mediated C1P metabolism attenuates acute liver injury by inhibiting the interaction between KEAP1 and NRF2. Exp Mol Med. 2024;56:946-58.
137. Kaur A, Patankar JV, de Haan W, et al. Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1. Diabetes. 2015;64:1168-79.
138. Baudrand R, Carvajal CA, Riquelme A, et al. Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients. Obes Surg. 2010;20:77-83.
139. Takashima M, Ogawa W, Hayashi K, et al. Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action. Diabetes. 2010;59:1608-15.
140. Jamwal R, Barlock BJ. Nonalcoholic fatty liver disease (NAFLD) and hepatic cytochrome P450 (CYP) enzymes. Pharmaceuticals. 2020;13:222.
141. Jorde R, Schirmer H, Wilsgaard T, et al. The DBP phenotype Gc-1f/Gc-1f is associated with reduced risk of cancer. The Tromsø study. PLoS One. 2015;10:e0126359.
142. Pittas AG, Dawson-Hughes B, Sheehan P, et al; D2d Research Group. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019;381:520-30.
143. Kawahara T, Suzuki G, Mizuno S, et al. Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population. BMJ. 2022;377:e066222.
144. Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126:1549-64.
145. Guilliams M, Bonnardel J, Haest B, et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell. 2022;185:379-96.e38.
